HDGFL2 and malaria: This has been identified and documented in several countries in South America; however, parasites carrying the mutation for HRP2 deletion have not been identified in countries west of the Panama Canal.24,25 To ensure the efficacy of the main diagnostic tool for malaria in Haiti, these 11 sites will continue to monitor for both molecular markers of antimalarial drug resistance and begin to monitor for parasite mutations that would interfere with the HRP2-based RDTs.